The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Comparative Metabolic Flux Profiling of Melanoma Cell Lines
Open accessAbstract
Metabolic rewiring is an established hallmark of cancer, but the details of this rewiring at a systems level are not well characterized. Here we acquire this insight in a melanoma cell line panel by tracking metabolic flux using isotopically labeled nutrients. Metabolic profiling and flux balance analysis were used to compare normal melanocytes to melanoma cell lines in both normoxic and hypoxic conditions. All melanoma cells exhibited the Warburg phenomenon; they used more glucose and produced more lactate than melanocytes. Other changes were observed in melanoma cells that are not described by the Warburg phenomenon. Hypoxic conditions increased fermentation of glucose to lactate in both melanocytes and melanoma cells (the Pasteur effect). However, metabolism was not strictly glycolytic, as the tricarboxylic acid (TCA) cycle was functional in all melanoma lines, even under hypoxia. Furthermore, glutamine was also a key nutrient providing a substantial anaplerotic contribution to the TCA cycle. In the WM35 melanoma line glutamine was metabolized in the "reverse" (reductive) direction in the TCA cycle, particularly under hypoxia. This reverse flux allowed the melanoma cells to synthesize fatty acids from glutamine while glucose was primarily converted to lactate. Altogether, this study, which is the first comprehensive comparative analysis of metabolism in melanoma cells, provides a foundation for targeting metabolism for therapeutic benefit in melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Numerous studies have reported that malignant cells use glutaminolysis under hypoxic conditions [82,83].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [82]
In the citing paper
“tumor cells with mutations in the TCA cycle or ETC (Mullen et al., 2011), or with hypoxia-induced suppression of oxidative metabolism (Metallo et al., 2011; Scott et al., 2011; Wise et al., 2011) use reductive carboxylation of α-KG to produce citrate and other precursors during growth.”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Scott et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
On Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Java Treeview—extensible visualization of microarray data
Saldanha, A. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth349 · Cited by 2,991
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
GeneCards Version 3: the human gene integrator
Safran, M., Dalah, I., Alexander, J., Rosen, N., Stein, T. I., Shmoish, M., Nativ, N., Bahir, I., Doniger, T., Krug, H., et al. (2010) · Database · doi:10.1093/database/baq020 · Cited by 2,134
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020
Research works printed but not linked: 4
- Russo, 2009, Int. J. Oncol., 34, 1481
- Yang, 2007, Pac. Symp. Biocomput., 181
- Shah, 2010, PLoS Genet., 6
- Eng, 2010, Sci. Signal, 3, ra31
Cited by
Sorted by citations
Glutamine and cancer: cell biology, physiology, and clinical opportunities
Hensley, C. T., Wasti, A. T., & DeBerardinis, R. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69600 · Cited by 1,262
ERK signalling: A master regulator of cell behaviour, life and fate
Lavoie, H., Gagnon, J., & Therrien, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0255-7 · Cited by 1,185
Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)
Zheng, J. (2012) · Oncology Letters · doi:10.3892/ol.2012.928 · Cited by 986
Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us?
DeBerardinis, R. J., & Thompson, C. B. (2012) · Cell · doi:10.1016/j.cell.2012.02.032 · Cited by 858
Yang, C., Ko, B., Hensley, C. T., Jiang, L., Wasti, A. T., Kim, J., Sudderth, J., Calvaruso, M. A., Lumata, L., Mitsche, M., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.025 · Cited by 679
Zheng, X., Boyer, L., Jin, M., Mertens, J., Kim, Y., Ma, L., Ma, L., Hamm, M., Gage, F. H., & Hunter, T. (2016) · eLife · doi:10.7554/elife.13374 · Cited by 671
“More details including the parameters of machine settings can be found in the publication from the center (Scott et al., 2011).”
BackgroundRoesch, A., Vultur, A., Bogeski, I., Wang, H., Zimmermann, K. M., Speicher, D., Körbel, C., Laschke, M. W., Gimotty, P. A., Philipp, S. E., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.003 · Cited by 670
RAF-MEK-ERK pathway in cancer evolution and treatment
Ullah, R., Yin, Q., Snell, A. H., & Wan, L. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.010 · Cited by 553
Tardito, S., Oudin, A., Ahmed, S. U., Fack, F., Keunen, O., Zheng, L., Miletic, H., Sakariassen, P. Ø., Weinstock, A., Wagner, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3272 · Cited by 557
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy
Sullivan, L. B., Gui, D. Y., & Heiden, M. G. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.85 · Cited by 406
Mitochondria as biosynthetic factories for cancer proliferation
Ahn, C. S., & Metallo, C. M. (2015) · Cancer & Metabolism · doi:10.1186/s40170-015-0128-2 · Cited by 399
Oldham, W. M., Clish, C. B., Yang, Y., & Loscalzo, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.021 · Cited by 364
“Given that PASMC proliferate in response to hypoxia, one interesting hypothesis is that the D2HG represents incomplete reductive carboxylation by IDH in these cells as has been observed in a variety of cancer cell lines (Gameiro et al., 2013; Scott et al., 2011; Wise et al., 2011).”
InfluentialMetabolic reprogramming in cancer: Unraveling the role of glutamine in tumorigenesis
Daye, D., & Wellen, K. E. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.02.002 · Cited by 387
Understanding metabolic regulation and its influence on cell physiology
Metallo, C. M., & Vander Heiden, M. G. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.018 · Cited by 367
Dysregulated metabolism contributes to oncogenesis
Hirschey, M. D., DeBerardinis, R. J., Diehl, A. M., Drew, J. E., Frezza, C., Green, M. F., Jones, L. W., Ko, Y. H., Le, A., Lea, M. A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.10.002 · Cited by 316
Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters
Marchiq, I., & Pouysségur, J. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1307-x · Cited by 300
The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer
Fontana, F., Giannitti, G., Marchesi, S., & Limonta, P. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.89942 · Cited by 309
Grassian, A. R., Parker, S. J., Davidson, S. M., Divakaruni, A. S., Green, C. R., Zhang, X., Slocum, K. L., Pu, M., Lin, F., Vickers, C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0772-t · Cited by 280
Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier
Vacanti, N. M., Divakaruni, A. S., Green, C. R., Parker, S. J., Henry, R. R., Ciaraldi, T. P., Murphy, A. N., & Metallo, C. M. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.024 · Cited by 277
Aerobic glycolysis and high level of lactate in cancer metabolism and microenvironment
Jiang, B. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.02.003 · Cited by 277
Kalyanaraman, B., Cheng, G., Hardy, M., Ouari, O., López, M., Joseph, J., Zielonka, J., & Dwinell, M. B. (2017) · Redox Biology · doi:10.1016/j.redox.2017.09.020 · Cited by 239
Chang, S., Yim, S., & Park, H. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0230-6 · Cited by 228
Świerczyński, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i9.2279 · Cited by 203
Fischer, G. M., Gopal, Y. N. V., McQuade, J. L., Peng, W., DeBerardinis, R. J., & Davies, M. A. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12661 · Cited by 200
Suppression of PGC-1α Is Critical for Reprogramming Oxidative Metabolism in Renal Cell Carcinoma
LaGory, E. L., Wu, C., Taniguchi, C. M., Ding, C. C., Chi, J., von Eyben, R., Scott, D. A., Richardson, A. D., & Giaccia, A. J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.006 · Cited by 198
Self-citationCorbet, C., Bastien, E., Draoui, N., Doix, B., Mignion, L., Jordan, B. F., Marchand, A., Vanherck, J., Chaltin, P., Schakman, O., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03525-0 · Cited by 189
Hall, A., Meyle, K. D., Lange, M. K., Klima, M., Sanderhoff, M., Dahl, C., Abildgaard, C., Thorup, K., Moghimi, S. M., Jensen, P. B., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.965 · Cited by 191
Filipp, F. V., Scott, D. A., Ronai, Z. A., Osterman, A. L., & Smith, J. W. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.00989.x · Cited by 193
Self-citationResistance to BRAF inhibitors induces glutamine dependency in melanoma cells
Baenke, F., Chaneton, B., Smith, M., van den Broek, N. J. F., Hogan, K., Tang, H., Virós, A., Martin, M. J., Galbraith, L. C. A., Girotti, M. R., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.08.003 · Cited by 191
Functional Specialization in Proline Biosynthesis of Melanoma
Ingeniis, J. D., Ratnikov, B. I., Richardson, A. D., Scott, D. A., Aza‐Blanc, P., De, S. K., Kazanov, M. D., Pellecchia, M., Ronai, Z. A., Osterman, A. L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045190 · Cited by 186
Self-citationCorazao-Rozas, P., Guerreschi, P., Jendoubi, M., André, F., Jonneaux, A., Scalbert, C., Garçon, G., Malet‐Martino, M., Balayssac, S., Rocchi, S., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1420 · Cited by 188
Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK
Moldogazieva, N. T., Mokhosoev, I. M., & Terentiev, A. A. (2020) · Cancers · doi:10.3390/cancers12040862 · Cited by 181
Lessons from patient-derived xenografts for better in vitro modeling of human cancer
Choi, S. Y. C., Lin, D., Gout, P. W., Collins, C. C., Xu, Y., & Wang, Y. Z. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.009 · Cited by 181
Tan, B., Young, D. A., Lu, Z.-H., Wang, T., Meier, T. I., Shepard, R. L., Roth, K. D. W., Zhai, Y. W., Huss, K., Kuo, M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.394510 · Cited by 181
Importance of glycolysis and oxidative phosphorylation in advanced melanoma
Ho, J., de Moura, M. B., Lin, Y., Vincent, G., Thorne, S. H., Duncan, L. M., Lin, H., Kirkwood, J. M., Becker, D., Houten, B. V., et al. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-76 · Cited by 173
Liu, W., Hancock, C. N., Fischer, J. W., Harman, M., & Phang, J. M. (2015) · Scientific Reports · doi:10.1038/srep17206 · Cited by 175
Metabolic rewiring in melanoma
Ratnikov, B. I., Scott, D. A., Osterman, A. L., Smith, J. W., & Ronai, Z. A. (2016) · Oncogene · doi:10.1038/onc.2016.198 · Cited by 176
Self-citationOncogene-Directed Alterations in Cancer Cell Metabolism
Nagarajan, A., Malvi, P., & Wajapeyee, N. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.06.002 · Cited by 169
HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells
Lee, S.-H., Golinska, M., & Griffiths, J. R. (2021) · Cells · doi:10.3390/cells10092371 · Cited by 169
Glucose-dependent de Novo Lipogenesis in B Lymphocytes
Dufort, F. J., Gumina, M. R., Ta, N. L., Tao, Y., Heyse, S. A., Scott, D. A., Richardson, A. D., Seyfried, T. N., & Chiles, T. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.551051 · Cited by 160
Self-citationMetabolic consequences of oncogenic IDH mutations
Parker, S. J., & Metallo, C. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.003 · Cited by 162
Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival
Pathria, G., Scott, D. A., Feng, Y., Lee, J. S., Fujita, Y., Zhang, G., Sahu, A. D., Ruppin, E., Herlyn, M., Osterman, A. L., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201899735 · Cited by 163
Self-citationLee, M. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i3.148 · Cited by 152
Metabolic Adaptations in Cancer Stem Cells
Yadav, U. P., Singh, T., Kumar, P., Sharma, P., Kaur, H., Sharma, S., Singh, S., Kumar, S., & Mehta, K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01010 · Cited by 158
Kluza, J., Corazao-Rozas, P., Touil, Y. S., Jendoubi, M., Maire, C., Guerreschi, P., Jonneaux, A., Ballot, C., Balayssac, S., Valable, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0979 · Cited by 161
Capello, M., Borgogno, S. F., Riganti, C., Chattaragada, M. S., Principe, M., Roux, C., Zhou, W., Petricoin, E. F., Cappello, P., & Novelli, F. (2015) · Oncotarget · doi:10.18632/oncotarget.6798 · Cited by 153
Natarajan, S. K., Zhu, W., Liang, X., Zhang, L., Demers, A., Zimmerman, M. C., Simpson, M. A., & Becker, D. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.07.002 · Cited by 148
VDAC Regulation: A Mitochondrial Target to Stop Cell Proliferation
Fang, D., & Maldonado, E. N. (2018) · Advances in cancer research · doi:10.1016/bs.acr.2018.02.002 · Cited by 142
Fessel, J. P., Hamid, R., Wittmann, B. M., Robinson, L. J., Blackwell, T., Tada, Y., Tanabe, N., Tatsumi, K., Hemnes, A. R., & West, J. D. (2012) · Pulmonary Circulation · doi:10.4103/2045-8932.97606 · Cited by 141
Zheng, X., Boyer, L. F., Jin, M., Kim, Y., Fan, W., Bardy, C., Berggren, W. T., Evans, R. M., Gage, F. H., & Hunter, T. R. (2016) · eLife · doi:10.7554/elife.13378 · Cited by 139
Molecular drivers of cellular metabolic reprogramming in melanoma
Abildgaard, C., & Guldberg, P. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.12.007 · Cited by 138
Global Profiling Strategies for Mapping Dysregulated Metabolic Pathways in Cancer
Benjamin, D. I., Cravatt, B. F., & Nomura, D. K. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.09.013 · Cited by 131
Liu, Q., Wang, Q., Xu, C. Y., Shao, W., Zhang, C., Liu, H., Jiang, Z., & Gu, A. (2017) · Scientific Reports · doi:10.1038/srep46339 · Cited by 127
On the Origin of ATP Synthesis in Cancer
Seyfried, T. N., Arismendi-Morillo, G., Mukherjee, P., & Chinopoulos, C. (2020) · iScience · doi:10.1016/j.isci.2020.101761 · Cited by 121
Gameiro, P. A., Laviolette, L. A., Kelleher, J. K., Iliopoulos, O., & Stephanopoulos, G. N. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.396796 · Cited by 126
The role of Hypoxia-Inducible Factor-1alpha and its signaling in melanoma
Malekan, M., Ebrahimzadeh, M. A., & Sheida, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111873 · Cited by 123
Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment
Avagliano, A., Fiume, G., Pelagalli, A., Sanità, G., Ruocco, M. R., Montagnani, S., & Arcucci, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00722 · Cited by 128
Kimura, R. H., Wang, L., Shen, B., Huo, L., Tummers, W. S. F. J., Filipp, F. V., Guo, H. H., Haywood, T., Abou‐Elkacem, L., Baratto, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11863-w · Cited by 120
Self-citationDesideri, E., Vegliante, R., & Ciriolo, M. R. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.02.023 · Cited by 116
In vivo maps of extracellular pH in murine melanoma by CEST–MRI
Castelli, D. D., Ferrauto, G., Cutrìn, J. C., Terreno, E., & Aime, S. (2013) · Magnetic Resonance in Medicine · doi:10.1002/mrm.24664 · Cited by 113
Profiling metabolic networks to study cancer metabolism
Hiller, K., & Metallo, C. M. (2012) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2012.11.001 · Cited by 113
Glutamine‐fueled mitochondrial metabolism is decoupled from glycolysis in melanoma
Filipp, F. V., Ratnikov, B. I., Ingeniis, J. D., Smith, J. W., Osterman, A. L., & Scott, D. A. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12000 · Cited by 115
Self-citationMetabolism and epigenetics: a link cancer cells exploit
Carrer, A., & Wellen, K. E. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.11.012 · Cited by 110
Luan, W., Zhou, Z., Ni, X., Xia, Y. F., Wang, J., Yan, Y., & Xu, B. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2582-z · Cited by 110
Mitochondrial Respiration - An Important Therapeutic Target in Melanoma
de Moura, M. B., Vincent, G., Fayewicz, S. L., Bateman, N. W., Hood, B. L., Sun, M., Suhan, J. P., Duensing, S. M., Yin, Y., Sander, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040690 · Cited by 105
Phannasil, P., Thuwajit, C., Warnnissorn, M., Wallace, J. C., MacDonald, M. J., & Jitrapakdee, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129848 · Cited by 103
Cesi, G., Walbrecq, G., Zimmer, A. D., Kreis, S., & Haan, C. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0667-y · Cited by 108
Human Milk Oligosaccharides Promote the Growth of Staphylococci
Hunt, K. M., Preuss, J., Nissan, C., Davlin, C. A., Williams, J. E., Shafii, B., Richardson, A. D., McGuire, S., Bode, L., & McGuire, M. A. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.00477-12 · Cited by 104
Self-citationMetabolic flexibility in melanoma: A potential therapeutic target
Ruocco, M. R., Avagliano, A., Granato, G., Vigliar, E., Masone, S., Montagnani, S., & Arcucci, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.016 · Cited by 106
Kim, H.-Y., Lee, H., Kim, S., Jin, H., Bae, J., & Choi, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-08433-9 · Cited by 104
Cheng, G., Zielonka, J., McAllister, D. M., Tsai, S., Dwinell, M. B., & Kalyanaraman, B. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.272 · Cited by 90
Mitochondrial oxidative phosphorylation in cutaneous melanoma
Kumar, P. R., Moore, J. A., Bowles, K. M., Rushworth, S. A., & Moncrieff, M. D. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01159-y · Cited by 92
Hopperton, K. E., Duncan, R. E., Bazinet, R. P., & Archer, M. C. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.10.016 · Cited by 91
Comes, S., Gagliardi, M., Laprano, N., Fico, A., Cimmino, A., Palamidessi, A., Cesare, D. D., Falco, S. D., Angelini, C., Scita, G., et al. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.09.001 · Cited by 90
The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4
Pinheiro, C. M., Miranda‐Gonçalves, V., Longatto‐Filho, A., Vicente, A. L. S. A., Berardinelli, G. N., Scapulatempo‐Neto, C., Costa, R. F. A., Viana, C. R., Reis, R. M., Baltazar, F., et al. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1175258 · Cited by 93
Activated lymphocytes as a metabolic model for carcinogenesis
Macintyre, A. N., & Rathmell, J. C. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-5 · Cited by 93
Press-pulse: a novel therapeutic strategy for the metabolic management of cancer
Seyfried, T. N., Yu, G. W., Maroon, J. C., & D’Agostino, D. P. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0178-2 · Cited by 86
Genetically-defined metabolic reprogramming in cancer
Mullen, A. R., & DeBerardinis, R. J. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.06.009 · Cited by 90
Roles of pyruvate carboxylase in human diseases: from diabetes to cancers and infection
Lao-On, U., Attwood, P. V., & Jitrapakdee, S. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1622-0 · Cited by 85
Oncogene-Driven Metabolic Alterations in Cancer
Min, H., & Lee, H. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.211 · Cited by 88
Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway
Kardos, G. R., Wastyk, H. C., & Robertson, G. P. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0048 · Cited by 84
Zhang, Y., Song, H., Li, M., & Lu, P. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1614 · Cited by 84
Glutamate and asparagine cataplerosis underlie glutamine addiction in melanoma
Ratnikov, B. I., Aza‐Blanc, P., Ronai, Z. A., Smith, J. W., Osterman, A. L., & Scott, D. A. (2015) · Oncotarget · doi:10.18632/oncotarget.3132 · Cited by 80
Self-citationLipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives
Pellerin, L., Carrié, L., Dufau, C., Nieto, L., Ségui, B., Levade, T., Riond, J., & Andrieu‐Abadie, N. (2020) · Cancers · doi:10.3390/cancers12113147 · Cited by 91
Metabolic and Bactericidal Effects of Targeted Suppression of NadD and NadE Enzymes in Mycobacteria
Rodionova, I. A., Schuster, B. M., Guinn, K. M., Sorci, L., Scott, D. A., Li, X., Kheterpal, I., Shoen, C. M., Cynamon, M. H., Locher, C. P., et al. (2014) · mBio · doi:10.1128/mbio.00747-13 · Cited by 82
Self-citationEstablishment of human iPSC-based models for the study and targeting of glioma initiating cells
Sancho-Martinez, I., Nivet, E., Xia, Y. F., Hishida, T., Aguirre, A., Ocampo, A., Ma, L., Morey, R. E., Krause, M. N., Zembrzycki, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms10743 · Cited by 81
MicroRNA 211 Functions as a Metabolic Switch in Human Melanoma Cells
Mazar, J., Qi, F., Lee, B., Marchica, J., Govindarajan, S. S., Shelley, J. P., Li, J., Ray, A., & Perera, R. J. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00762-15 · Cited by 80
Sayed, S. M. E., Mohamed, W. G., Seddik, M.-A. H., Ahmed, A.-S. A., Mahmoud, A. G., Amer, W. H., Nabo, M. M. H., Hamed, A., Ahmed, N. S., & Abd-Allah, A. A.-R. (2014) · 癌症:英文版 · doi:10.5732/cjc.013.10111 · Cited by 77
Exploiting tumor metabolism: challenges for clinical translation
Heiden, M. G. V. (2013) · Journal of Clinical Investigation · doi:10.1172/jci72391 · Cited by 79
MicroRNAs as regulators of mitochondrial function: Role in cancer suppression
Tomasetti, M., Neužil, J., & Dong, L. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.09.002 · Cited by 78
The Metabolic Origins of Mannose in Glycoproteins
Ichikawa, M., Scott, D. A., Losfeld, M., & Freeze, H. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.544064 · Cited by 76
Self-citationVDAC–Tubulin, an Anti-Warburg Pro-Oxidant Switch
Maldonado, E. N. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00004 · Cited by 76
Romano, V., Belviso, I., Venuta, A., Ruocco, M. R., Masone, S., Aliotta, F., Fiume, G., Montagnani, S., Avagliano, A., & Arcucci, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105283 · Cited by 78
Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin
Kim, E. H., Lee, J.-H., Oh, Y., Koh, I., Shim, J., Park, J., Choi, J., Yun, M., Jeon, J. Y., Huh, Y., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now174 · Cited by 72
Preter, G. D., Neveu, M.-A. C., Danhier, P., Brisson, L., Payen, V. L., Porporato, P. E., Jordan, B. F., Sonveaux, P., & Gallez, B. (2015) · Oncotarget · doi:10.18632/oncotarget.6272 · Cited by 69
Wen, H., An, Y., Xu, W. J., Kang, K. W., & Park, S. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201410380 · Cited by 65
Isotope tracing in adult zebrafish reveals alanine cycling between melanoma and liver
Naser, F. J., Jackstadt, M. M., Fowle-Grider, R., Spalding, J. L., Cho, K., Stancliffe, E., Doonan, S. R., Kramer, E. T., Yao, L., Krasnick, B. A., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.04.014 · Cited by 65
Chemotherapy Resistance: Role of Mitochondrial and Autophagic Components
Bahar, E., Han, S., Kim, J., & Yoon, H. (2022) · Cancers · doi:10.3390/cancers14061462 · Cited by 67
HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer
Burkhart, R. A., Pineda, D. M., Chand, S. N., Romeo, C., Londin, E. R., Karoly, E. D., Cozzitorto, J. A., Rigoutsos, I., Yeo, C. J., Brody, J. R., et al. (2013) · RNA Biology · doi:10.4161/rna.25274 · Cited by 64
Time-resolved fluorescence lifetime for cutaneous melanoma detection
Pires, L., Nogueira, M. S., Pratavieira, S., Moriyama, L. T., & Kurachi, C. (2014) · Biomedical Optics Express · doi:10.1364/boe.5.003080 · Cited by 63
Metadata
- Authors
- Scott, D. A., Richardson, A. D., Filipp, F. V., Knutzen, C. A., Chiang, G. G., Ronai, Z. A., Osterman, A. L., & Smith, J. W.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Osterman, Andrei L.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 286
- Issue
- 49
- Pages
- 42626-42634
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC3234981
- OpenAlex
- W1976603231
- Cited by
- 328
- References
- 44
- Citations by year
- 2026: 7 · 2025: 21 · 2024: 16 · 2023: 15 · 2022: 21 · 2021: 32 · 2020: 30 · 2019: 21 · 2018: 22 · 2017: 25 · 2016: 20 · 2015: 33 · 2014: 20 · 2013: 20 · 2012: 25
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-147978, R00CA154887, CA-154887, K99CA154887, R21CA147978, P01CA128814, CA-128814)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- melanoma, Warburg effect, hypoxia, Pasteur effect, glycolysis, lactic acid production, TCA cycle, glutamine metabolism, reductive TCA cycle, fatty acid synthesis, melanocytes, isotopic labeling, flux balance analysis, metabolic therapy
- MeSH terms
- Hypoxia, Citric Acid Cycle, Fermentation, Glucose, Glutamine, Glycolysis, Humans, Ketoglutaric Acids, Gas Chromatography-Mass Spectrometry, Melanocytes, Melanoma, Models, Biological, Skin Neoplasms, Lactic Acid, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review